| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 02/14/2007 | CN1912111A Engomphosis and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen |
| 02/14/2007 | CN1911952A Preparation technology of 18F labelled positive electron radioactivity tracer precusor |
| 02/14/2007 | CN1911947A Synthesis technology of 18F labelled positive electron radioactive tracer precusor |
| 02/14/2007 | CN1299777C Stilbene derivatives and their use for binding and imaging amyloid plaques |
| 02/13/2007 | US7176008 Process for producing activated thrombin-activatable fibrinolysis inhibitor |
| 02/13/2007 | US7175830 Labelling with radioactive materials |
| 02/08/2007 | WO2007016466A2 Single wall nanotube constructs and uses therefor |
| 02/08/2007 | WO2007015094A2 Use of peptides for imaging blood clots |
| 02/08/2007 | WO2007014460A1 Cancerous disease modifying antibodies |
| 02/08/2007 | WO2006121852A3 Anti-cd19 antibody therapy for autoimmune disease |
| 02/08/2007 | WO2006019424A3 Stable aqueous colloidal lanthanide oxides |
| 02/08/2007 | US20070032694 Stents with a radioactive surface coating, processes for their production and their use for restenosis prophylaxis |
| 02/08/2007 | US20070031931 Biosynthetic binding proteins for immuno-targeting |
| 02/08/2007 | US20070031334 Vitamin-targeted imaging agents |
| 02/08/2007 | US20070031333 Novel F-18 labeled annexin V, synthesis thereof, and use thereof |
| 02/08/2007 | US20070031332 Angiogenic agents from plant extracts, gallic acid, and derivatives |
| 02/08/2007 | US20070031331 Treatment of Disorders |
| 02/08/2007 | US20070031330 Isolated monoclonal antibody produced by the hybridoma; primary tumors and tumor metastases |
| 02/08/2007 | US20070031329 Method of obtaining gallium-68 and use thereof and device for carrying out said method |
| 02/08/2007 | US20070031328 Radiolabeled-pegylation of ligands for use as imaging agents |
| 02/08/2007 | US20070031327 Nanoradiopharmaceuticals and methods of use |
| 02/08/2007 | US20070031326 Compounds that selectively bind to membranes of apoptotic cells |
| 02/08/2007 | CA2617462A1 Cancerous disease modifying antibodies |
| 02/07/2007 | EP1749815A1 Radioactive tyrosine derivative, method for producing same, labeling agent for positron imaging and medical agent for assessing grade of malignancy of tumor respectively composed of radioactive tyrosine derivative, and method for detecting tumor |
| 02/07/2007 | EP1749516A2 Lock and key micelles |
| 02/07/2007 | EP1749026A1 Labelled adrenomedullin derivatives and their use for imaging and therapy |
| 02/07/2007 | EP1748992A1 Trimeric macrocyclic substituted aminoisophthalate halophenyl derivatives |
| 02/07/2007 | EP0971748B1 Tetraaza- or n2s2- complexants, and their use in radiodiagnostics or radiotherapy |
| 02/07/2007 | CN1298390C Smulaneous imaging of cardiac perfusion and vitronection receptor targeted imaging agent |
| 02/06/2007 | US7173061 For diagnosis or in vivo imaging of Amyloid-associated diseases such as diabetes; radiolabelled |
| 02/06/2007 | US7172749 Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy |
| 02/01/2007 | WO2007014237A2 Radioprotective agents |
| 02/01/2007 | US20070027307 Microwave method for preparing radiolabelled gallium complexes |
| 02/01/2007 | US20070026464 Biologically active synthetic thyrotropin and cloned gene for producing same |
| 02/01/2007 | US20070025915 Determination of AM-binding proteins and the association of adrenomedullin (AM) therewith |
| 02/01/2007 | US20070025914 Bronchioalveolar stem cells and uses thereof |
| 02/01/2007 | US20070025913 Immunoglobulin which specifically binds endothelial cell-specific polypeptides; for use as evaluative tool in immunodiagnostic and drug efficacy studies |
| 02/01/2007 | US20070025912 Cytotoxicity mediation of cells evidencing surface expression of CD63 |
| 02/01/2007 | US20070025911 Breast cancer; hybridomas; cell lines; kits |
| 02/01/2007 | US20070025910 Anticancer therapy |
| 02/01/2007 | CA2616380A1 Radioprotective agents |
| 02/01/2007 | CA2615589A1 A radioactive surface source and a method for producing the same |
| 02/01/2007 | CA2591907A1 Phospholipid ether analogs for detecting and treating cancer |
| 01/31/2007 | EP1747018A2 Method for the production of carbon nanotubes that are ferromagnetically filled in part and carry biomolecules, and use thereof in diagnosis and therapy |
| 01/31/2007 | EP0869821B1 Stereoisomers of fatty acid analogs for diagnostic imaging |
| 01/31/2007 | CN1905904A Novel imaging agents comprising caspase-3 inhibitors |
| 01/31/2007 | CN1905900A Targeting of ERB antigens |
| 01/30/2007 | US7169618 Magnetic particles and methods of producing coated magnetic particles |
| 01/30/2007 | US7169588 Bioconversion of a fermentable carbon source to 1,3-propanediol by a single microorganism |
| 01/30/2007 | US7169377 Radioligands for the TRP-M8 receptor and methods therewith |
| 01/30/2007 | CA2254421C Method of affixing radioisotopes onto the surface of a device |
| 01/30/2007 | CA2210751C Anti-cd6 monoclonal antibodies and their uses |
| 01/25/2007 | WO2007011680A2 Ligands to radiation-induced molecules |
| 01/25/2007 | WO2007010534A2 Imaging protocols |
| 01/25/2007 | WO2007010211A1 Radiolabelled nanoparticles |
| 01/25/2007 | WO2007009191A1 Method for treating cancer |
| 01/25/2007 | WO2006084030A3 Small-molecule hsp90 inhibitors |
| 01/25/2007 | WO2006070290A8 Agents and methods for early diagnosis and monitoring of alzheimer's disease and other neurological disorders |
| 01/25/2007 | US20070020265 administering non-blocking anti-CD20 antibody and carrier; fusion proteins; rheumatoid arthritis |
| 01/25/2007 | US20070020185 Diagnostic imaging contrast agents with extended blood retention |
| 01/25/2007 | US20070020184 Diagnostic imaging contrast agents with extended blood retention |
| 01/25/2007 | US20070020179 Acute leukemia and lymphoblastic lymphoma-specific CD43 epitope and use thereof |
| 01/25/2007 | US20070020178 For detecting and locating recurrence of cancer, radiation and drug resistance, and/or metastasis |
| 01/25/2007 | US20070020177 Radiometal complex compositions |
| 01/25/2007 | US20070020176 Contrast agent |
| 01/25/2007 | CA2615744A1 Plexin d1 as a target for tumor diagnosis and therapy |
| 01/24/2007 | EP1746421A2 Diagnostic and therapeutic application of antibodies against the urokinase receptor |
| 01/24/2007 | EP1745803A2 Improved process for the production of a radioactive aerosol |
| 01/24/2007 | EP1745799A2 Compositions and methods of treating tumors |
| 01/24/2007 | EP1745123A1 Cholesterol-producing yeast strains and uses thereof |
| 01/24/2007 | EP1744789A1 Activatable particles, preparations and uses |
| 01/24/2007 | EP1744758A2 Radiopharmaceutical and methods of synthesis and use thereof |
| 01/24/2007 | EP1744737A2 Cysteamines for treating complications of hypercholesterolemia and diabetes |
| 01/24/2007 | EP1590317B1 ENANTIOMER-PURE (4S,8S)- AND (4R, 8R)-4-P-NITROBENZYL-8-METHYL-3, 6, 9-TRIAZA- SP 3 /sp N, SP 6 /SP N, SP 9 /SP N-TRICARBOXYMETHYL-1, 11-UNDECANOIC ACID AND DERIVATIVES THEREOF, METHOD FOR PRODUCING THEM, AND THEIR USE FOR PRODUCING PHARMACEUTICAL AGENTS |
| 01/24/2007 | EP1390405B1 Preparation of cholecystokinin agonists and antagonists and their therapeutic and diagnostic use |
| 01/24/2007 | EP1257285B1 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer |
| 01/24/2007 | CN1901941A Conjugates of angiotensin ii and an imaging moiety |
| 01/24/2007 | CN1901894A Inhibitor imaging agents |
| 01/24/2007 | CN1901839A Soluble TCR molecules and methods of use |
| 01/24/2007 | CN1901795A Methods, compositions and devices for inducing stasis in cells, tissues, organs, and organisms |
| 01/23/2007 | US7166297 Comprises liposomes attached to prodrugs through phosphonate linkages; phospholipases; targets liver/spleen |
| 01/23/2007 | US7166295 Methods of treatment and diagnostic visualization, particularly in cancer |
| 01/23/2007 | US7166286 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for prophylaxis and detection of cancers |
| 01/23/2007 | CA2107400C Method of grinding pharmaceutical substances |
| 01/18/2007 | WO2007009128A2 Methods and compositions for 10beryllium complex probes |
| 01/18/2007 | WO2007008855A2 Method of treating human volume expansion mediated hypertension employing resibufogenin |
| 01/18/2007 | WO2007008232A2 Locoregional internal radionuclide ablation of abnormal tissues. |
| 01/18/2007 | WO2007007021A1 Gentisic acid for stabilisig 123-i radiopharmaceuticals |
| 01/18/2007 | WO2007006071A1 Improved process for the production of a radioactive aerosol |
| 01/18/2007 | WO2004071468A3 Short immunomodulatory oligonucleotides |
| 01/18/2007 | US20070014725 Conjugates of macrocyclic metal complexes with biomolecules and their use for the production of agents for NMR diagnosis and radiodiagnosis as well as radiotherapy |
| 01/18/2007 | US20070014724 inhibit the biological activity of multiple interferon (IFN) alpha subtypes but do not substantially inhibit the biological activity of IFN alpha 21, IFN beta or IFN omega; autoimmune diseases, transplant rejection and graft versus host disease; immunoconjugates |
| 01/18/2007 | US20070014723 Methods and compositions for 10Beryllium complex probes |
| 01/18/2007 | US20070014722 Method of treating human volume expansion mediated hypertension employing resibufogenin |
| 01/18/2007 | US20070014721 Hydrazide conjugates as imaging agents |
| 01/18/2007 | US20070014720 Antibodies directed to CD20 and uses thereof |
| 01/18/2007 | US20070014719 Steroid analogs and characterization and treatment methods |
| 01/18/2007 | US20070014718 Kits for gastric emptying measurement |
| 01/18/2007 | DE102005033903A1 New perfluoroalkyl-containing metal complexes, useful for production of contrast agents for use in e.g. NMR and X-ray diagnostics, necrosis imaging and in radiodiagnostics and radiotherapy |
| 01/18/2007 | CA2613619A1 Sp1 polypeptides, modified sp1 polypeptides and uses thereof |